Trial Profile
DPP-4 Inhibition and Thiazolidinedione for Diabetes Mellitus Prevention (DInT DM Study)
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Sitagliptin (Primary)
- Indications Diabetes mellitus; Glucose intolerance
- Focus Therapeutic Use
- Acronyms DInT DM
- 01 May 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 26 Jul 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 23 Jun 2011 Planned initiation date changed from 1 Jul 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov.